Project Grant K23AR085758
Award Date 6/1/26
Completion Date 5/31/31
Dollars Obligated $178K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.11M Project Grant award dated March 4, 2026, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports a 24-month research initiative focused on developing and validating a scalable imaging approach to measure muscle bioenergetics in patients with chronic kidney disease (CKD). The research...
- Federal Grant Award Summary The University of Florida received a $544,689 Project Grant awarded August 6, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to improve diagnosis and outcomes for diffuse alveolar hemorrhage (DAH) in systemic lupus erythematosus (SLE). The five-year research initiative, extending through June 30, 2030, utilizes a pristane-induced lupus...
- Federal Project Grant Award Summary Mayo Clinic received a $127,273 project grant award dated September 5, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research project, extending through August 31, 2027, investigates the role of TFEB (a transcription factor) in regulating age-associated B cells (ABCs) and their contribution to systemic autoimmunity, with...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $829,319 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026 through November 30, 2030. The research project aims to identify collaborating factors driving DDX41 mutant pathology in myelodysplastic syndromes (MDS) by investigating how DDX41 mutations...
- Federal Grant Award Summary The University of Washington received a $412,569 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded May 1, 2026, with completion scheduled for April 30, 2028. This research project will develop and validate biomarker assays to measure inflammatory modes of programmed cell death—specifically pyroptosis, necroptosis, and...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $267,423 to The Hospital for Special Surgery Fund, Inc. (HSS Foundation) on September 16, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This two-year-and-eleven-month project, concluding August 31, 2028, supports research to develop a novel biomarker for assessing immunosuppressive drug safety in patients with immune...
- Federal Grant Award Summary The Regents of the University of Minnesota received a $668,135 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, through August 31, 2030. This award funds basic immunological research investigating the differential functions of LYN splice variants (LYNA and LYNB kinases) in myeloid cell signaling...
- Federal Grant Award Summary Yale University received a $462,052 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct biomedical research investigating the role of ETS2 (Erythroblast Transformation Specific 2) transcription factor in monocyte activation related to systemic lupus erythematosus (SLE). The research project, initiated February 19, 2026 and concluding January 31,...
- This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $172,560 in federal funding to The Trustees of Columbia University in the City of New York to conduct translational research investigating the role of SAP (SLAM-Associated Protein) positive T cells in lupus nephritis. The five-year research project, which commenced June 1, 2026 and...
- Project Grant Summary Rutgers The State University of New Jersey, Robert Wood Johnson Health Sciences (RBHS)-School of Nursing received a $637,018 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded August 7, 2025, with completion targeted for June 30, 2030. The grant funds basic and translational research investigating the role of natural killer (NK)...